reglab/housing_qa huggingface dataset:
VA Code § 54.1-3439 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3439. Application for nonrestricted manufacturing permit; fee

Every person desiring to manufacture any drug or proprietary medicines shall annually apply to the Board for a nonrestricted manufacturing permit. The application shall be accompanied by the required fee. Separate applications shall be made and separate permits issued for each specific place of manufacturing. Each such permit shall expire annually on a date determined by the Board in regulation.1970, c. 650, § 54-524.40; 1972, c. 798; 1976, c. 614; 1980, c. 288; 1988, c. 765; 1996, cc. 37, 407; 2008, c. 320.
VA Code § 54.1-3440 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3440. Persons to whom nonrestricted permit is granted

No person shall be granted a nonrestricted permit as a manufacturer unless he is of good moral character and properly equipped as to land, buildings, equipment and safeguards against diversion to carry out the functions of a manufacturer with due regard to the protection of the public safety.1970, c. 650, § 54-524.41; 1976, c. 614; 1988, c. 765.
VA Code § 54.1-3441 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3441. Restricted manufacturing permit; application; fee; separate application and permit for each place of manufacturing

Every person desiring to manufacture a proprietary medicine or to repackage medical gases shall apply to the Board for a restricted manufacturing permit. The application shall be accompanied by the required fee. Separate applications shall be made and separate permits issued for each separate place of manufacturing.1976, c. 614, § 54-524.41:1; 1980, c. 288; 1988, c. 765; 1996, cc. 37, 407.
VA Code § 54.1-3442 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3442. When permit not to be granted; regulations

No person shall be granted a restricted manufacturing permit as a manufacturer unless such person is properly equipped as to buildings and equipment to carry out the functions of a manufacturer with due regard to the protection of the public health. The Board shall promulgate regulations in order to carry out the provisions of this section.1976, c. 614, § 54-524.41:2; 1988, c. 765.
VA Code § 54.1-3442.01 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3442.01. Registration of nonresident manufacturer; renewal

A. Any manufacturer located outside the Commonwealth who ships prescription drugs into the Commonwealth shall be registered with the Board. The nonresident manufacturer shall renew such registration annually on a date determined by the Board in regulation and shall notify the Board within 30 days of any substantive change in the information previously submitted.B. The nonresident manufacturer shall at all times maintain a valid, unexpired license, permit, or registration in the state in which it is located or current registration as a manufacturer or repackager with the federal Food and Drug Administration and shall furnish proof of such upon application and at each renewal.C. Records of prescription drugs distributed into the Commonwealth shall be maintained in such a manner that they are readily retrievable from records of shipments into other jurisdictions and shall be provided to the Board, its authorized agent, or any agent designated by the Superintendent of the Department of State Police upon request within seven days of receipt of such request.2016, c. 221.
VA Code § 54.1-3442.1 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3442.1. Definitions

As used in this article, unless the context requires a different meaning:"Investigational drug, biological product, or device" means a drug, biological product, or device that has successfully completed Phase I of a clinical trial but has not been approved for general use by the U.S. Food and Drug Administration and remains under investigation in a clinical trial."Terminal condition" means a condition caused by injury, disease, or illness from which, to a reasonable degree of medical probability, a patient cannot recover and (i) the patient's death is imminent or (ii) the patient is in a persistent vegetative state."Treating physician" means a physician who is providing or has previously provided medical treatment or evaluation to and has or previously had an ongoing treatment relationship with the person.2015, cc. 655, 656.
VA Code § 54.1-3442.3 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3442.3. Expanded access to investigational drugs, biological products, or devices; cost; insurance coverage

A. A manufacturer of an investigational drug, biological product, or device may make such investigational drug, biological product, or device available to a person who meets the criteria set forth in subsection A of § 54.1-3442.2; however, nothing in this article shall require a manufacturer of an investigational drug, biological product, or device to make such investigational drug, biological product, or device available to such person.B. A manufacturer that makes an investigational drug, biological product, or device available to a person who meets the criteria set forth in subsection A of § 54.1-3442.2 may provide the investigational drug, biological product, or device to the person free of charge or may require the person to pay the costs of, or the costs associated with, the manufacture of the investigational drug, biological product, or device.C. An insurer proposing to issue individual or group accident and sickness insurance policies providing hospital, medical and surgical, or major medical coverage on an expense-incurred basis, a corporation providing individual or group accident and sickness subscription contracts, or a health maintenance organization providing a health care plan for health care services may provide coverage for costs related to treatment of a person's terminal condition with an investigational drug, biological product, or device; however, nothing in this article shall require an insurer proposing to issue individual or group accident and sickness insurance policies providing hospital, medical and surgical, or major medical coverage on an expense-incurred basis, a corporation providing individual or group accident and sickness subscription contracts, or a health maintenance organization providing a health care plan for health care services to provide coverage for costs related to treatment of a person's terminal condition with an investigational drug, biological product, or device.2015, cc. 655, 656.
VA Code § 54.1-3442.4 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3442.4. Limitation of liability

A. Notwithstanding any other provision of law to the contrary, a health care provider as defined in § 8.01-581.1 who recommends an investigational drug, biological product, or device to a person who meets the criteria set forth in subsection A of § 54.1-3442.2 shall be immune from civil liability for any adverse action, condition, or other outcome resulting from the person's use of the investigational drug, biological product, or device.B. Notwithstanding any other provision of law to the contrary, a manufacturer, distributor, administrator, health care provider as defined in § 8.01-581.1, sponsor, or physician who manufactures, supplies, distributes, administers, prescribes, or recommends an investigational drug, biological product, or device to a person who meets the criteria set forth in § 54.1-3442.2 shall be immune from suit and liability caused by, arising out of, or relating to the design, development, clinical testing and investigation, manufacture, labeling, distribution, sale, purchase, donation, dispensing, prescription, recommendation, administration, efficacy, or use of such investigational drug, biological product, or device made available to such person.C. No claim or cause of action against a manufacturer, distributor, administrator, health care provider as defined in § 8.01-581.1, sponsor, or physician who manufactures, supplies, distributes, administers, prescribes, or recommends an investigational drug, biological product, or device to a person who meets the criteria set forth in § 54.1-3442.2 shall exist in any state court for claims of property, personal injury, or death caused by, arising out of, or relating to the design, development, clinical testing and investigation, manufacture, labeling, distribution, sale, purchase, donation, dispensing, prescription, recommendation, administration, efficacy, or use of such investigational drug, biological product, or device made available to such person.D. No health care provider as defined in § 8.01-581.1 who recommends, prescribes, administers, distributes, or supplies an investigational drug, biological product, or device to a person who meets the criteria set forth in § 54.1-3442.2 shall be deemed to have engaged in unprofessional conduct, or shall be adversely affected in any decision relating to licensure, on such grounds.E. Nothing in this article shall require a person to violate or act in contravention of any federal or state law as such law relates to the prescribing, dispensing, administration, or use of an investigational drug, biological product, or device.2015, cc. 655, 656.
VA Code § 54.1-3442.5 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3442.5. Definitions

As used in this article:"Botanical cannabis," "cannabis oil," "cannabis product," and "usable cannabis" have the same meanings as specified in § 54.1-3408.3."Cannabis dispensing facility" means a facility that (i) has obtained a permit from the Board pursuant to § 54.1-3442.6; (ii) is owned, at least in part, by a pharmaceutical processor; and (iii) dispenses cannabis products produced by a pharmaceutical processor to a registered patient, his registered agent, or, if such patient is a minor or an incapacitated adult as defined in § 18.2-369, such patient's parent or legal guardian."Designated caregiver facility" has the same meaning as defined in § 54.1-3408.3."Pharmaceutical processor" means a facility that (i) has obtained a permit from the Board pursuant to § 54.1-3408.3 and (ii) cultivates Cannabis plants intended only for the production of cannabis oil, botanical cannabis, and usable cannabis, produces cannabis products, and dispenses cannabis products to a registered patient, his registered agent, or, if such patient is a minor or an incapacitated adult as defined in § 18.2-369, such patient's parent or legal guardian."Practitioner" has the same meaning as specified in § 54.1-3408.3."Registered agent" has the same meaning as specified in § 54.1-3408.3.2017, c. 613; 2018, cc. 246, 809; 2019, c. 690; 2020, c. 1278; 2021, Sp. Sess. I, cc. 205, 227, 228.
VA Code § 54.1-3442.8 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3442.8. Criminal liability; exceptions

No agent or employee of a pharmaceutical processor or cannabis dispensing facility shall be prosecuted under Chapter 11 (§ 4.1-1100 et seq.) of Title 4.1 or § 18.2-248, 18.2-248.1, or 18.2-250 for possession or manufacture of marijuana or for possession, manufacture, or distribution of cannabis products, subject to any civil penalty, denied any right or privilege, or subject to any disciplinary action by a professional licensing board if such agent or employee (i) possessed or manufactured such marijuana for the purposes of producing cannabis products in accordance with the provisions of this article and Board regulations or (ii) possessed, manufactured, or distributed such cannabis products that are consistent with generally accepted cannabis industry standards in accordance with the provisions of this article and Board regulations.2017, c. 613; 2020, cc. 764, 1278; 2021, Sp. Sess. I, cc. 227, 228, 550, 551.
VA Code § 54.1-3444 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3444. Controlled substances included by whatever name designated

The controlled substances listed or to be listed in the schedules in this chapter are included by whatever official, common, usual, chemical, or trade name designated.1972, c. 798, § 54-524.84:2; 1988, c. 765.
VA Code § 54.1-3445 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3445. Placement of substance in Schedule I

The Board shall place a substance in Schedule I if it finds that the substance:1. Has high potential for abuse; and2. Has no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision.1972, c. 798, § 54-524.84:3; 1988, c. 765.
VA Code § 54.1-3447 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3447. Placement of substance in Schedule II

The Board shall place a substance in Schedule II if it finds that:1. The substance has high potential for abuse;2. The substance has currently accepted medical use in treatment in the United States, or currently accepted medical use with severe restrictions; and3. The abuse of the substance may lead to severe psychic or physical dependence.1972, c. 798, § 54-524.84:5; 1988, c. 765.
VA Code § 54.1-3449 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3449. Placement of substance in Schedule III

The Board shall place a substance in Schedule III if it finds that:1. The substance has a potential for abuse less than the substances listed in Schedules I and II;2. The substance has currently accepted medical use in treatment in the United States; and3. Abuse of the substance may lead to moderate or low physical dependence or high psychological dependence.1972, c. 798, § 54-524.84:7; 1988, c. 765.
VA Code § 54.1-3451 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3451. Placement of substance in Schedule IV

The Board shall place a substance in Schedule IV if it finds that:1. The substance has a low potential for abuse relative to substances in Schedule III;2. The substance has currently accepted medical use in treatment in the United States; and3. Abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances in Schedule III.1972, c. 798, § 54-524.84:9; 1988, c. 765.
VA Code § 54.1-3453 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3453. Placement of substance in Schedule V

The Board shall place a substance in Schedule V if it finds that:1. The substance has low potential for abuse relative to the controlled substances listed in Schedule IV;2. The substance has currently accepted medical use in treatment in the United States; and3. The substance has limited physical dependence or psychological dependence liability relative to the controlled substances listed in Schedule IV.1972, c. 798, § 54-524.84:11; 1988, c. 765.
VA Code § 54.1-3454 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3454. Schedule V

The controlled substances listed in this section are included in Schedule V:1. Any compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, which also contains one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation, valuable medicinal qualities other than those possessed by the narcotic drug alone:Not more than 200 milligrams of codeine, or any of its salts, per 100 milliliters or per 100 grams;Not more than 100 milligrams of dihydrocodeine, or any of its salts, per 100 milliliters or per 100 grams;Not more than 100 milligrams of ethylmorphine, or any of its salts, per 100 milliliters or per 100 grams;Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit;Not more than 100 milligrams of opium per 100 milliliters or per 100 grams;Not more than 0.5 milligrams of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.The Board may except by regulation any compound, mixture, or preparation containing any depressant substance listed in subdivision 1 from the application of all or any part of this chapter and such substances so excepted may be dispensed pursuant to § 54.1-3416.2. Unless specifically excepted or listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:Pyrovalerone.3. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also referred to as BRV; UCB-34714; Briviact);Ezogabine [N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester]-2779;Gabapentin [1-(aminomethyl)cyclohexaneacetic acid];Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide];Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid].1972, c. 798, § 54-524.84:12; 1976, c. 614; 1977, c. 302; 1979, c. 387; 1984, c. 186; 1986, c. 463; 1988, c. 765; 1992, c. 737; 1994, c. 763; 2003, c. 640; 2006, c. 346; 2010, c. 423; 2012, c. 541; 2017, c. 612; 2019, c. 214.
VA Code § 54.1-3455 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3455. Schedule VI

The following classes of drugs and devices shall be controlled by Schedule VI:1. Any compound, mixture, or preparation containing any stimulant or depressant drug exempted from Schedules III, IV or V and designated by the Board as subject to this section.2. Every drug, not included in Schedules I, II, III, IV or V, or device, which because of its toxicity or other potentiality for harmful effect, or the method of its use, or the collateral measures necessary to its use, is not generally recognized among experts qualified by scientific training and experience to evaluate its safety and efficacy as safe for use except by or under the supervision of a practitioner licensed to prescribe or administer such drug or device.3. Any drug, not included in Schedules I, II, III, IV or V, required by federal law to bear on its label prior to dispensing, at a minimum, the symbol "Rx only," or which bears the legend "Caution: Federal Law Prohibits Dispensing Without Prescription" or "Caution: Federal Law Restricts This Drug To Use By Or On The Order Of A Veterinarian" or any device which bears the legend "Caution: Federal Law Restricts This Device To Sales By Or On The Order Of A _______________." (The blank should be completed with the word "Physician," "Dentist," "Veterinarian," or with the professional designation of any other practitioner licensed to use or order such device.)1972, c. 798, § 54-524.84:13; 1976, c. 614; 1977, c. 302; 1988, c. 765; 1999, c. 605.
VA Code § 54.1-3456 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3456. Controlled substance analog

A controlled substance analog shall, to the extent intended for human consumption, be treated, for the purposes of any state law, as a controlled substance in Schedule I or II. A controlled substance analog shall be considered to be listed on the same schedule as the drug or class of drugs which it imitates.1987, c. 447, § 54-524.84:14; 1988, c. 765; 2014, cc. 674, 719.
VA Code § 54.1-3456.1 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3456.1. Drugs of concern

The Board may promulgate regulations designating specific drugs and substances, including any controlled substance or other drug or substance where there has been or there is the actual or relative potential for abuse, as drugs of concern. Drugs or substances designated as drugs of concern shall be reported to the Department of Health Professions and shall be subject to reporting requirements for the Prescription Monitoring Program established pursuant to Chapter 25.2 (§ 54.1-2519 et seq.).2014, c. 664; 2017, c. 181; 2019, c. 214.
VA Code § 54.1-3458 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3458. Violations

A. Any person who violates any of the provisions of § 54.1-3457 shall be guilty of a Class 2 misdemeanor.B. No person shall be subject to the penalties of this section for having violated subdivisions 1 and 3 of § 54.1-3457 if he establishes a guaranty or undertaking signed by, and containing the name and address of, the person residing in this Commonwealth from whom he received in good faith the article, to the effect that such article is not adulterated or misbranded within the meaning of this chapter.C. No publisher, radio-broadcast licensee, or agency or medium for the dissemination of an advertisement, except the manufacturer, packer, distributor, or seller of the article to which a false advertisement relates, shall be liable under this section for the dissemination of such false advertisement, unless he has refused, on the request of the Board, to furnish the Board the name and post-office address of the manufacturer, packer, distributor, seller, or advertising agency, residing in this Commonwealth who caused him to disseminate such advertisement.1970, c. 650, § 54-524.87; 1988, c. 765.
VA Code § 54.1-3459 (2021)
2021 Code of Virginia|Title 54.1 - Professions and Occupations|Chapter 34 - Drug Control Act|§ 54.1-3459. Tagging of adulterated or misbranded drugs, devices, or cosmetics; condemnation; destruction; expenses

A. Whenever a duly authorized agent of the Board finds, or has probable cause to believe, that any drug, device, or cosmetic is adulterated, or so misbranded as to be dangerous or fraudulent, within the meaning of this chapter or is in violation of § 54.1-3457, he shall affix to such article a tag or other appropriate marking, giving notice that such article is, or is suspected of being, adulterated or misbranded or in violation of § 54.1-3457 and has been detained. The tag shall also warn all persons not to remove or dispose of such article by sale or otherwise until permission for removal or disposal is given by an authorized agent or the court. It shall be unlawful for any person to remove or dispose of such detained article by sale or otherwise without permission.B. When an article is adulterated or misbranded or is in violation of § 54.1-3421, the Board may petition the circuit court in whose jurisdiction the article is detained for condemnation of such article. When an authorized agent finds that an article which has been detained is not adulterated or misbranded, or in violation of § 54.1-3421, he shall remove the tag or other marking.C. If the court finds that a detained article is adulterated or misbranded, or in violation of § 54.1-3421, such article shall, after entry of the decree, be destroyed at the expense of the claimant, under the supervision of an authorized agent, and all court costs and fees, and storage and other proper expenses, shall be levied against the claimant or his agent. When the adulteration or misbranding can be corrected by proper labeling or processing of the article, the court shall order the article to be properly labeled or processed. The expense of the supervision shall be paid by the claimant. The article shall be returned to the claimant and the bond shall be discharged on the representation to the court by the Board that the article is no longer in violation of this chapter, and that the expenses of such supervision have been paid.1970, c. 650, § 54-524.88; 1988, c. 765.